Get the Daily Brief
Latest Biotech News
Recursion Slashes 20% of Staff as Funding Tightens
Amid biopharma capital market challenges and pipeline streamlining, AI-driven drug discovery firm Recursion announced a 20% workforce reduction. The move reflects broader funding contractions in...
Penn State Scientists Spin Edible Nano-Fibers from Milk and Plant Polymers
A novel electrospinning technique developed at Penn State creates biodegradable, edible nanofibers combining milk protein casein and plant-based cellulose. This innovation could transform...
FDA Clears Nuvation Lung Cancer Oral Drug Amid Competitive Market
The FDA has approved Nuvation Bio’s oral medication Ibtrozi (taletrectinib) for treating ROS1-positive metastatic non-small cell lung cancer. Key clinical trials revealed strong response rates and...
Bristol Myers Squibb Expands Radiopharma Pipeline With $1.35B Philochem Prostate Cancer Deal
Bristol Myers Squibb, through its RayzeBio subsidiary, secured global rights to Philochem’s OncoACP3, an experimental radiopharmaceutical for prostate cancer diagnosis and therapy, in a deal...
CRISPR Homologous Recombination Efficiency Enhanced by Autophagy Induction
Researchers at the Korea Research Institute of Chemical Technology demonstrated that inducing autophagy, a cellular degradation process, significantly shifts DNA repair from error-prone...
New CAR-T Cell Therapy Targets Solid Tumors Using Eva1 Antigen
Japanese researchers engineered next-generation CAR-T therapies exploiting Eva1 (MPZL2) protein expressed on lung, pancreatic, and liver cancers. This antigen’s small size enables stronger...
Breakthrough Electrospinning Creates Biodegradable and Edible Fibers from Milk and Plant Proteins
Penn State researchers pioneered an electrospinning technique combining casein milk proteins with plant-derived cellulose (HPMC) to fabricate ultra-fine nanofibers potentially usable in...
Innovative AI Hardware Accelerator Speeds 6G Wireless Signal Processing
MIT researchers unveiled a photonic chip designed to perform AI computations for wireless signal classification at nanosecond timescales. This hardware accelerator offers approximately 100 times...
Alamar Biosciences and Partners Launch Major Proteomics Initiative in Alzheimer's Research
Alamar Biosciences, in collaboration with the Alzheimer's Disease Data Initiative and Gates Ventures, launched a large-scale plasma proteomic profiling project targeting Alzheimer's disease and...
Recursion Biotech Cuts 20% Workforce Amid Funding and Pipeline Challenges
Salt Lake City-based AI-driven drug discovery company Recursion announced a 20% workforce reduction, reflecting pipeline pruning and a challenging capital environment. The restructuring aims to...
Eli Lilly and Juvena Strike $650M Deal to Advance Muscle Health Therapies
Eli Lilly has entered into a strategic partnership with Juvena Therapeutics, committing over $650 million in milestones to develop novel muscle-boosting drugs. Juvena's AI-driven platform will...
Merck Gains FDA Nod for Pediatric RSV Antibody as Vaccine Advisory Faces Uncertainty
Merck & Co. secured FDA approval for Enflonsia (cesrovimab), a long-acting monoclonal antibody to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants....
FDA Approves Nuvation’s Ibtrozi for Advanced Lung Cancer
The U.S. Food and Drug Administration has granted approval to Nuvation Bio for Ibtrozi (taletrectinib), an oral medication targeting advanced ROS1-positive non-small cell lung cancer (NSCLC)....
Recursion cuts 20% of workforce amid pipeline cuts
Recursion Pharmaceuticals announced a workforce reduction of approximately 20% following strategic cuts to its drug development pipeline amidst challenging capital markets. The downsizing reflects...
SpliceBio lands $135M to fund novel gene therapy
SpliceBio secured $135 million in Series B financing from major pharma venture arms, propelling clinical development of a pioneering dual AAV gene therapy for Stargardt disease. This substantial...
Merck RSV drug approved – CDC committee in flux
Merck's monoclonal antibody Enflonsia gains FDA approval for preventing RSV in infants, entering a competitive market alongside Sanofi and AstraZeneca's product. This regulatory milestone...
Biomanufacturing growth contrasts with lab space market fluctuations
The U.S. life sciences sector experiences dichotomous trends with burgeoning biomanufacturing investments exceeding $270 billion fueling domestic expansion, driven by reshoring and supply chain...
Innovations in diagnostic technologies and therapeutic platforms
Emerging diagnostic tools harness AI, nanotechnology, and advanced materials to improve disease detection and patient care. Technologies include an AI-powered nanopore viral detection platform...
Regulatory shifts and challenges impact biotech and healthcare sectors
Policy decisions and administrative actions are significantly affecting the biotech and healthcare environment. NIH staff protests oppose drastic budget cuts and grant cancellations, citing...
Biotech funding and strategic collaborations highlight industry growth
Significant capital inflows and partnerships shape the biotech landscape. SpliceBio secured $135 million in a Series B round to advance gene therapy for Stargardt disease, engaging top strategic...